Mariusz Pytkowski Selected Research

Ventricular Tachycardia

10/2022	Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review.
1/2020	Identification of the ventricular tachycardia circuit using the Advisor HD Grid multielectrode mapping catheter.
1/2017	Efficacy and tolerability of mexiletine treatment in patients with recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator shocks.
9/2014	Effectiveness of antitachycardia pacing therapy after primary prophylaxis implantation of implantable defibrillators in coronary artery disease patients.
12/2003	[Successful radiofrequency catheter ablation of the symptomatic ventricular tachycardia in structurally normal heart. Case report].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariusz Pytkowski Research Topics

Disease

11	Atrial Fibrillation 01/2023 - 10/2002
7	Heart Failure 01/2022 - 04/2004
6	Cardiac Arrhythmias (Arrythmia) 10/2022 - 04/2012
5	Ventricular Tachycardia 10/2022 - 12/2003
4	Ventricular Fibrillation 10/2022 - 03/2006
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 09/2010 - 10/2005
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2019 - 10/2005
2	Thrombosis (Thrombus) 01/2023 - 10/2005
2	Heart Diseases (Heart Disease) 10/2022 - 01/2022
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 04/2012
2	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2021 - 01/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2018 - 09/2014
2	Reciprocating Tachycardia 11/2016 - 12/2014
2	Supraventricular Tachycardia 12/2014 - 09/2010
2	Myocardial Infarction 01/2012 - 03/2006
1	Carcinogenesis 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Atrial Flutter (Flutter, Atrial) 01/2020
1	Infections 01/2020
1	Systolic Heart Failure 12/2018
1	Tachycardia (Tachyarrhythmias) 10/2017
1	Pulmonary Embolism 01/2016
1	Endocarditis 07/2014
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013
1	Hemorrhage 10/2002

Drug/Important Bio-Agent (IBA)

5	Antazoline (Antazoline Phosphate)FDA Link 01/2022 - 09/2012
2	Mexiletine (Mexitil)FDA LinkGeneric 10/2022 - 01/2017
2	Anti-Arrhythmia AgentsIBA 10/2022 - 09/2012
2	Amiodarone (Amiodarona)FDA LinkGeneric 12/2018 - 01/2017
2	vernakalantIBA 12/2018 - 09/2012
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Trinitrotoluene (TNT)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Troponin T (Troponin T1)IBA 01/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 04/2021
1	ORALIT (ORS)IBA 09/2015
1	Adenosine Triphosphate (ATP)IBA 09/2014
1	butaneIBA 03/2006
1	Heparin (Liquaemin)FDA LinkGeneric 10/2005

Therapy/Procedure

10	Therapeutics 01/2023 - 10/2002
9	Electric Countershock (Cardioversion) 01/2023 - 10/2002
9	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2022 - 10/2005
6	Catheter Ablation 01/2022 - 12/2003
6	Radiofrequency Ablation 01/2020 - 09/2010
3	Defibrillators (Defibrillator) 03/2006 - 10/2002
2	Catheters 01/2021 - 01/2020
2	Cardiac Resynchronization Therapy 12/2018 - 10/2014
1	Contraindications 01/2016
1	Cardiac Resynchronization Therapy Devices 10/2014
1	Secondary Prevention 09/2010